Impactive Capital LP 13D and 13G filings for Meridian Bioscience, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-10-28 4:30 pm Sale |
2022-10-27 | 13D | Meridian Bioscience, Inc. VIVO |
Impactive Capital LP | 1,910,919 4.400% |
-495,639 (-20.60%) |
Filing |
| 2022-10-18 4:45 pm Sale |
2022-10-14 | 13D | Meridian Bioscience, Inc. VIVO |
Impactive Capital LP | 2,406,558 5.500% |
-494,628 (-17.05%) |
Filing |
| 2022-09-19 4:51 pm Sale |
2022-09-15 | 13D | Meridian Bioscience, Inc. VIVO |
Impactive Capital LP | 2,901,186 6.600% |
-639,355 (-18.06%) |
Filing |
| 2022-09-07 4:36 pm Sale |
2022-09-02 | 13D | Meridian Bioscience, Inc. VIVO |
Impactive Capital LP | 3,540,541 8.100% |
-781,428 (-18.08%) |
Filing |
| 2022-02-04 5:09 pm Purchase |
2022-01-25 | 13D | Meridian Bioscience, Inc. VIVO |
Impactive Capital LP | 4,321,969 9.900% |
4,321,969 (New Position) |
Filing |